⌘+K

Post-results note

Preparing for a wide range of outcomes in 2027 - Q3 review

Elsa Brismar

2026-10-23

08:30 CEST

A weak Q3 reflected missing royalty and delivery timing, while cost savings are now visible. More important, in our view, is the company’s ability to convert its pipeline into orders. The company is preparing for a wide range of 2027 outcomes, balancing tighter cost control with flexibility to ramp up if larger orders materialise. We lower our earnings expectations for 2027, but leave 2028 and long-term estimates unchanged, and maintain our fair value range of SEK18–35 per share.

Weaker-than-expected Q3. Sales were SEK33m, down 61% Y/Y and 42% below our SEK57m estimate. Instead of the sequential step-up we expected, sales fell about 11% Q/Q. Management attributes the weak top line mainly to supply chain delays and deliveries being pushed to Q4 and 2027.

Converting pipeline into firm orders is key. The CEO believes it is too early to conclude that the market is improving but says that interest from Power Generation has taken off, with the Bosch MoU supporting this. Projects in Power Generation can be significantly larger, meaning a single order could materially transform the top line, although timing and conversion remain difficult to assess. PowerCell is preparing for a wide range of 2027 outcomes, with its asset-light model and Bosch partnership allowing capacity to scale while trimming the cost base.

Cost savings are larger and earlier. Combined selling, administrative and R&D costs fell 25% Y/Y, and the annual cost level is expected to be about SEK50m lower in 2027.

Estimate revisions: We adjust our 2026 estimates to include a EUR5m licence fee from Bosch in Q4, lifting profitability by 8%. We make minor top-line revisions and incorporate PowerCell’s updated cost-reduction guidance. This results in a 3%-point reduction to our 2027e EBITDA margin, while leaving our 2028e profitability assumptions unchanged.

Valuation. We keep our fair value range of SEK18–35 per share.

Sweden

Capital Goods

Latest share price

SEK

14.8

-3.65%

18 Nov 2026 15:46 CET

Fair value range

SEK

18.0

—

35.0

19 Oct 2026

Market cap

SEK

860

m

Next report

Q4

3 Feb 2027

Key stats

Year

2026e

EPS

-1.76

EPS (Adj.)

-1.76

Sales Growth

-26.72%

EPS Growth (Adj.)

85.20%

P/E

P/E (Adj.)

EV/EBITA

-8.5

EV/EBITDA

-12.4

Learn more

About DNB Carnegie Access

DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.

Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.

Private Banking

Tailored wealth management. Your financial future, personalized.

Montrose

A digital investment platform designed for passionate investors.

DNB Carnegie

Leading Nordic investment bank and wealth management.

© Copyright DNB Carnegie Investment Bank AB